leisure time -WSS

leisure time

author：Wikipedia 2025-09-28 19:18:51 - browse：2

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： FDA approval of Sarepta Duchenne genetic therapy gives me hope

WSS

Malaria cases in Florida and Texas: Here’s what you need to know

Apple is now the first public company to be valued at $3 trillion

What's changing in Medicare's open enrollment this year?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Life sciences deals on track to hit lowest point since 2017

Wellcome Trust names Røttingen as its new CEO

leisure time

leisure time

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

How should state employee insurance handle Wegovy?

Trump demands the U.S. pay no more for drugs than other countries … again

Female surgeons have lower rates of long

In age of alternative facts, a scholarly course on calling out crap

Medicare to cover more brain scans related to Alzheimer’s drugs

United colonoscopy coverage change 'may cost lives,' doctors say

Akero's treatment for NASH falls short in cirrhosis study

Peter Hotez and the public health issue of online harassment

Novavax promises a turnaround & Lilly roils the obesity market

explore

Readout LOUD podcast: Merger Mondays, Ozempic panic

European regulators consider appeal over Amylyx ALS drug

State Dept. review finds Biden bears some blame for Afghanistan failures

Anesthesiologist group: stop taking Ozempic before surgery

Wildfire smoke exposes gaps in outdoor worker protections

Virginia high school admissions case could be legal follow

focus

explore

hotspot

entertainment